We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
In response to the ongoing shortage of rabies vaccines in the UK, the Medicines and Healthcare products Regulatory Agency has approved that Sanofi Pasteur MSD import Verorab® rabies vaccine in order that supply is maintained.
Verorab® is unlicensed in the UK but has been used in the past during the rabies vaccine shortage of 2008/9. Verorab® should be administered using a patient specific direction. This vaccine is widely used throughout Europe and is approved by the World Health Organisation.
Verorab® has the same schedule as Rabies Vaccine BP® and Rabipur®. If a patient has already started a course of rabies vaccination with Rabipur® or Rabies Vaccine BP® the course can be completed with Verorab® since the vaccines may be used interchangeably to provide protection pre- or post-exposure.
